Search

everythinglearnresearchcommunity

for

Search:↓

Many patients with Alopecia Areata have underlying autoimmune disorders, especially thyroid issues.

Certain types of alopecia areata are linked to allergies, autoimmune diseases, and family history.

Alopecia patients have more mast cells in their scalps, especially in severe cases and older age, with alopecia areata showing the highest increase.

Bimatoprost is safe but not effective for severe eyelash loss from alopecia areata, possibly helping those with less loss.

Patients with alopecia areata in Saudi Arabia understand the condition's seriousness but still face significant psychological challenges.

Higher MPV and CRP levels may indicate more severe alopecia areata.

Mesenchymal Stem Cell Conditioned Media can significantly regrow hair in alopecia areata patients.

Ritlecitinib effectively improves hair growth in alopecia areata patients, regardless of hair loss pattern.

Late-onset alopecia areata in Taiwanese patients is more common in women, usually starts at age 57, often involves less than 10% hair loss, and may have a minimal link to thyroid issues.

Etanercept may not prevent alopecia areata from coming back.

Dupilumab may help regrow hair in people with atopic dermatitis.

Ustekinumab significantly improved psoriasis, vitiligo, and alopecia areata in a patient.

Patients with chronic graft-versus-host disease often have skin problems like vitiligo and alopecia areata.

The treatment for alopecia areata with diphenylcyclopropenone was unsuccessful.

Infliximab may cause hair loss in Crohn's disease patients.

Etanercept improved arthritis and psoriasis but caused hair loss, which healed after switching to sulfasalazine.

Insulin therapy helped a man with autoimmune issues regrow his hair.

Patients with alopecia areata have higher oxidative stress and lower antioxidant levels.

Alopecia areata causes unpredictable hair loss and emotional distress, with no cure and limited treatment options.

Trichoscopy helps correctly diagnose alopecia areata, not syphilitic alopecia, in patients with recent syphilis.

PRP is a promising alternative for alopecia areata due to its safety and patient satisfaction.

Ocrelizumab may cause delayed hair loss in some patients.

Secukinumab can cause hair loss, which may improve after stopping the medication.

Using a laser with bimatoprost solution works better for hair regrowth in alopecia areata than bimatoprost alone.

Dupilumab may help hair regrowth in some patients with severe atopic dermatitis, but results vary.

Lower zinc levels are linked to more severe hair loss in alopecia areata.

A girl with a rare genetic condition affecting hair and nails also developed a common type of hair loss, suggesting a possible genetic link.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

Ruxolitinib effectively regrows hair in most patients with severe hair loss.

Alopecia areata often starts before age 20, is more common in women, and may have a genetic link with other autoimmune diseases.